The Board of Directors of Sapporo Clinical Laboratory Inc. has authorized a buyback plan on May 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,007 JPY | -0.59% | -8.79% | +0.60% |
1st Jan change | Capi. | |
---|---|---|
+0.60% | 2.17Cr | |
-5.95% | 925.08Cr | |
+32.54% | 132.42Cr | |
-7.72% | 36Cr | |
+0.79% | 27Cr | |
+12.22% | 23Cr | |
-38.76% | 9.37Cr | |
-9.17% | 8.69Cr | |
+19.44% | 5.96Cr |
- Stock Market
- Equities
- 9776 Stock
- News Sapporo Clinical Laboratory Inc.
- Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.